1987
DOI: 10.1016/0378-4347(87)80472-3
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous determination of diazepam and its active metabolites in rat serum, brain and cerebrospinal fluid by high-performance liquid chromatography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

1990
1990
2008
2008

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 10 publications
0
9
0
Order By: Relevance
“…On the basis of the literature, we can estimate that DZ at the dose of 5 mg/kg will be quickly metabolized to its active metabolites N-desmethyldiazepam and oxazepam in mice, and that hardly any DZ should be present in the brain after 2 h (Coutinho et al, 1969;Greenblatt and Sethy, 1990). N-desmethyldiazepam, which has roughly the same affinity to BZ receptors and the same hypnotic potency as DZ (but less anticonvulsant potency than diazepam) (Frey and Löscher, 1982;Gobbi et al, 1987;Klockowski and Levy, 1987), disappears from the brain at around 12 h, whereas oxazepam has the longest elimination half-life of the active DZ metabolites and might be detectable at a very low level still at 24 h but unlikely to be detected at 48 h (Greenblatt and Sethy, 1990). However, oxazepam has clearly less hypnotic and anticonvulsant efficacy than DZ (Frey and Löscher, 1982;Klockowski and Levy, 1987).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…On the basis of the literature, we can estimate that DZ at the dose of 5 mg/kg will be quickly metabolized to its active metabolites N-desmethyldiazepam and oxazepam in mice, and that hardly any DZ should be present in the brain after 2 h (Coutinho et al, 1969;Greenblatt and Sethy, 1990). N-desmethyldiazepam, which has roughly the same affinity to BZ receptors and the same hypnotic potency as DZ (but less anticonvulsant potency than diazepam) (Frey and Löscher, 1982;Gobbi et al, 1987;Klockowski and Levy, 1987), disappears from the brain at around 12 h, whereas oxazepam has the longest elimination half-life of the active DZ metabolites and might be detectable at a very low level still at 24 h but unlikely to be detected at 48 h (Greenblatt and Sethy, 1990). However, oxazepam has clearly less hypnotic and anticonvulsant efficacy than DZ (Frey and Löscher, 1982;Klockowski and Levy, 1987).…”
Section: Discussionmentioning
confidence: 99%
“…N-desmethyldiazepam, which has roughly the same affinity to BZ receptors and the same hypnotic potency as DZ (but less anticonvulsant potency than diazepam) (Frey and Löscher, 1982;Gobbi et al, 1987;Klockowski and Levy, 1987), disappears from the brain at around 12 h, whereas oxazepam has the longest elimination half-life of the active DZ metabolites and might be detectable at a very low level still at 24 h but unlikely to be detected at 48 h (Greenblatt and Sethy, 1990). However, oxazepam has clearly less hypnotic and anticonvulsant efficacy than DZ (Frey and Löscher, 1982;Klockowski and Levy, 1987). Thus, it is unlikely that the possible residual oxazepam is directly involved in the glutamate receptor modification 24-72 h after a single injection of DZ.…”
Section: Discussionmentioning
confidence: 99%
“…The procedure was adapted from the method reported by Klockowski and Levy (1987). For the unknown samples, the whole brain was removed, weighed, placed in an ice-cold tube containing 2.5 mg medazepam (internal standard) and 1.5 mL borate buffer (pH 9).…”
Section: Determination Of Diazepam and Its Active Metabolites (Desmetmentioning
confidence: 99%
“…In the past, the CSF of rats was assayed infrequently for neurogenic molecules because of the difficulty of collection and low sample volume yields. However, with the advent of more sensitive assay techniques such as enzyme-linked immunosorbent assay and high-performance liquid chromatography (Klockowski and Levy, 1987), the low CSF yield from rats is no longer a limitation in utilization for biomarker measurement in a variety of toxicities and neurological disorders. Numerous techniques have been described for CSF collection in rats permanently implanted with cannulae or by guided cannulae (Curzon et al, 1985;De La Riva and Yeo, 1985;Jolkkonen et al, 1986;Sanvitto et al, 1987;Dingemanse et al, 1988;Sokomba et al, 1988;Takemoto, 1991;Westergren and Johansson, 1991;Halonen et al, 1992;Consiglio and Lucion, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Numerous techniques have been described for CSF collection in rats permanently implanted with cannulae or by guided cannulae (Curzon et al, 1985;De La Riva and Yeo, 1985;Jolkkonen et al, 1986;Sanvitto et al, 1987;Dingemanse et al, 1988;Sokomba et al, 1988;Takemoto, 1991;Westergren and Johansson, 1991;Halonen et al, 1992;Consiglio and Lucion, 2000). Ylitalo et al (1976) and Klockowski and Levy (1987) described the collection of CSF from the cisterna magna of anesthetized rats via percutaneous puncture. CSF from rats is routinely analyzed in many pharmaco-toxicologic (Curzon et al, 1985;De La Riva and Yeo, 1985;Jolkkonen et al, 1986;Kornhuber et al, 1986b;Takemoto, 1991) and biochemistry (Ylitalo et al, 1976;Westergren and Johansson, 1991) research studies.…”
Section: Introductionmentioning
confidence: 99%